What Is the 90–60 Rule for Antibiotics? Understanding Antibiotic Resistance and Treatment Success
Author: Dr Sagar Rajkuwar, ENT Specialist, Nashik, Maharashtra, India
🌐 www.entspecialistinnashik.com
The “90-60 rule” is a clinical finding in infectious disease and microbiology that outlines the forecast accuracy of laboratory antibiotic testing.
It states that:
- Treatment is successful in 90% of infections caused by bacteria that are classified as “susceptible” in a laboratory.
- Human bodies can still experience positive treatment results for 60% of lab test-diagnosed “resistant” infections.
What causes this?
Disk diffusion tests and other lab procedures are performed in extremely regulated settings, including culture dishes. The real-world efficacy of an antibiotic is different from its laboratory profile because the human body is far more complex.
- Why (in 10% of cases) vulnerable outcomes fail: Either the patient’s immune system is severely compromised or the medication may not reach the exact location of the infection (for example, poor penetration into the brain or abscesses).
- What Makes Unresistant Findings Successful (40% of occurrences): Fighting infections is a huge responsibility of the human immune system. Additionally, it’s possible that combination therapies are working together or that drugs are reaching greater levels in specific tissues than they would in a lab dish.
How Clinical Practice Is Guided by It
The rule emphasizes the value of individualizing treatment since in vitro tests are not always completely predicting of clinical success.
- If a patient is visibly getting better with an initial, broad-spectrum antibiotic, doctors may decide to keep giving them that medication even if laboratory cultures subsequently reveal that the pathogen is “resistant” to that drug.
- Lack of improvement: Conversely, physicians will utilize susceptibility reports to raise or lower the antibiotic regimen if a patient is not clinically reacting.
Warning: The 60-90 rule is a general epidemiological rule. Based on the patient’s specific clinical picture, a healthcare professional should always decide whether to change, carry on, or stop using an antibiotic.
Table of Contents
- Introduction
- Why Is Antimicrobial Susceptibility Testing Important?
- Why Isn’t a Sensitive Antibiotic Effective in Every Instance?
- Why Do Certain Resistant Antibiotics Still Work?
- The Role of Clinical Assessment
- The Increasing Threat to Global Health: Antibiotic Resistance
- The Significance of Antibiotic Stewardship
- De-escalation and Escalation Therapy
- In Clinical Practice, How Does the 90–60 Rule Work?
- Dealing with infections that are multidrug resistant
- Conclusion
- FAQ: 60–90 Guidelines for Using Antibiotics
Introduction
Effective treatment necessitates the identification of the microorganism responsible for an infection. After bacteria, fungi, viruses, and parasites are the most prevalent infectious organisms.
Antimicrobial Susceptibility Testing (AST) is frequently done in microbiology labs to check for fungal and bacterial infections. Which antibiotics would probably work against a particular microorganism may be identified with this test. However, susceptibility testing for parasitic and viral diseases is less common.
Laboratory testing is crucial to treatment decisions, but clinical outcomes don’t always correspond exactly with laboratory findings. The microbiology 90–60 rule explains this observation.
Why Is Antimicrobial Susceptibility Testing Important?
The first step is to determine what species is responsible for the infection. Additionally, doctors must determine if the organism is susceptible to or resistant to any accessible antibacterial medications.
AST (Antimicrobial Susceptibility Testing) helps in identifying:
- What antibiotics are expected to be effective?
- What antibiotics are probably not going to work?
- The most effective course of therapy for a patient
In general, effective antibiotics may stop or kill bacteria. This outcome is less likely to occur with resistant antibiotics.
Yet, sometimes clinical practice results in unanticipated results. Even if laboratory tests indicate that they are resistant to the antibiotics they are taking, some patients still get better. Some patients may not react even when taking antibiotics that seem vulnerable.
The basis of the 90–60 rule is this apparent contradiction.
The 90-60 Rule: What Is It?
The 90-60 rule is a commonly known clinical observation that explains the correlation between laboratory susceptibility results and treatment results in the real world.
In accordance with this rule:
- Approximately 90% of patients with infections are successfully treated with antibiotics that are reported as susceptible.
- About 60% of patients may still respond clinically to antibiotics that have been deemed resistant.
This does not imply that lab testing is unreliable. Instead, it emphasizes how difficult it is to duplicate the intricacy of the human body in a lab setting.
Why Isn’t a Sensitive Antibiotic Effective in Every Instance?
Cultivation media are used to conduct laboratory testing under controlled circumstances. Human bodies are much more intricate.
Treatment success depends on a number of factors, including:
- The immune response of the patient
- How bad the infection is
- Absorption of drugs
- Penetration of tissues
- Liver and renal functions
- Metabolism and excretion of drugs
- Other medical conditions exist.
Therefore, even with excellent laboratory results, a vulnerable antibiotic may occasionally fall short.
Why Do Certain Resistant Antibiotics Still Work?
The Minimum Inhibitory Concentration (MIC) can be used to categorize an organism as resistant in a lab study. Additional defensive mechanisms in the human body, however, cannot be totally evaluated by laboratory testing.
Treatment success may be enhanced by a number of variables, including:
- A powerful immune system
- Excessive antibiotic levels at the infection site
- Early detection and treatment.
- Infected tissue removed surgically
- Antibiotic therapy in combination
Therefore, laboratory tests may indicate resistance, yet some patients experience clinical improvement.
The Role of Clinical Assessment
The 90–60 rule emphasizes the importance of clinical evaluation as well as laboratory data.
Physicians ought to think about:
- Signs
- Results of the physical exam
- Sensitivity and culture reports
- Level of contamination
- The patient’s response to the treatment
- Fundamental medical issues
Instead of relying solely on laboratory results, treatment choices should always be made on an individual basis.
The Increasing Threat to Global Health: Antibiotic Resistance
Globally, antimicrobial resistance (AMR) is among the most serious public challenges.
Infections are more difficult to cure when bacteria become antibiotic resistant. This might result in:
- Lengthier hospital stays
- more expensive healthcare expenses
- More problems
- Increased mortality risk
Antimicrobial resistance could become a much more significant worldwide health concern in the future if proper infection control procedures and antibiotic stewardship aren’t put in place.
The Significance of Antibiotic Stewardship
To postpone the spread of antibiotic resistance, responsible usage of antibiotics is required.
Important antibiotic stewardship techniques include:
- Only administering antibiotics when necessary
- Choosing the Most Suitable Antibiotic
- Using the right dose and duration
- In light of the findings of culture and sensitivity
- Avoiding the use of broad-spectrum antibiotics when it is not necessary
- Promoting control and infection prevention
In order to maintain the effectiveness of antibiotics for future generations, these procedures are helpful.
De-escalation and Escalation Therapy
What is De-Escalation Treatment?
After culture findings identify a sensitive organism, de-escalation entails changing from a broad-spectrum antibiotic to a narrower-spectrum antibiotic.
The advantages are:
- Decrease in antimicrobial resistance
- Reduced treatment expenses
- Adverse effects are reduced.
What Does Escalation Therapy Mean?
Changing to a more potent or broad-spectrum antibiotic if the first course of treatment fails or lab tests reveal resistance is known as escalation.
Modern antibacterial management is based on both methods.
In Clinical Practice, How Does the 90–60 Rule Work?
Before culture results are known, patients with severe infections usually get empirical antibiotic treatment.
Culture reports from the lab are typically available between 24 and 72 hours.
Even if laboratory testing afterward implies resistance, physicians may continue the current therapy if a patient improves clinically during this time. This shows that the 90–60 rule is in effect.
Treatment, however, should be changed in accordance with culture and sensitivity findings if the patient is not getting better.
Dealing with infections that are multidrug resistant
Some bacteria, like species of Enterobacter, can quickly become resistant. Repeat cultures and susceptibility testing may be required in these situations because resistance patterns can shift quickly.
Physicians may utilize: for multidrug-resistant infections.
- Antibiotic therapy in combination
- More potent antimicrobial medications
- Customized treatment regimens depending on susceptibility testing
Targeting bacteria through several methods may improve outcomes with combination therapy.
Conclusion
Why laboratory susceptibility findings don’t always accurately forecast clinical results is explained by the 90–60 rule for antibiotics.
Despite the fact that most infections are effectively cured with susceptible antibiotics, some resistant antibiotics may continue to function due to the immune system’s activity, the drug’s concentration, and other patient-specific factors.
The finest treatment decisions are made by combining:
- Clinical judgement
- Results from the laboratory
- Patient reaction
- The tenets of antibiotic stewardship
Understanding the 90–60 rule aids healthcare professionals in making educated judgements while assisting the international struggle against antimicrobial resistance.
FAQ: 60–90 Guidelines for Using Antibiotics
For antibiotics, what is the 90-60 rule?
The 90–60 rule states that, in approximately 90% of patients, antibiotics determined to be susceptible in laboratory tests are effective in the clinic, while in around 60% of cases, antibiotics found to be resistant may still be beneficial due to host immune responses and other clinical factors.
Why do antibiotics that are resistant occasionally still have an effect?
Despite lab findings of bacterial resistance, factors such as the patient’s immune system, drug concentration at the infection site, and surgical drainage can aid in infection management.
Does the 90–60 rule imply that antibiotic resistance is irrelevant?
No, no. A major global health worry continues to be antibiotic resistance. The 90–60 rule merely emphasizes that laboratory findings must be considered in conjunction with the patient’s clinical state.
Even if the culture report reveals resistance, may physicians prescribe an antibiotic?
An antibiotic may be continued by a doctor if a patient is exhibiting a high level of clinical improvement in certain circumstances. The choice should always be made using skilled medical opinion.
AST is the study of how effectively an antibiotic fights a bacterial infection. The AST method helps clinicians select appropriate antibiotic treatments for infectious diseases.
Laboratory test known as antimicrobial susceptibility testing is used to ascertain if bacteria or fungi are susceptible, intermediary, or resistant to particular antimicrobial treatments.
What distinguishes resistant and susceptible bacteria?
Treatment using a certain antibiotic is more likely to be successful for susceptible bacteria, whereas it is less likely to be effective for resistant bacteria.
What impact does the immune system have on the effectiveness of antibiotics?
Even if lab testing indicates a reduced antibiotic efficacy, a strong immune system can help eliminate bacteria and enhance treatment results.
Antibiotic stewardship is what?
Antibiotic stewardship is the conscious application of antibiotics to minimize side effects, avoid antimicrobial resistance, and enhance patient outcomes.
What are escalation and de-escalation antibiotic strategies?
When treatment is ineffective, escalation entails changing to a more potent antibiotic, whereas de-escalation entails changing to a more restricted-spectrum antibiotic. once culture arises determine which creature is sensitive.
What makes antimicrobial resistance a global concern?
Antimicrobial resistance exacerbates the difficulty of treating infections, escalates healthcare expenses, lengthens hospitalization durations, and heightens the likelihood of severe illness and fatality globally.
Is it possible for culture reports to evolve with time?
Yes. Certain microorganisms can quickly build up resistance. Repeat cultures and susceptibility testing may be required to direct treatment in some diseases.
Is it necessary for people to stop taking antibiotics after they start to feel better?
No. Unless their healthcare provider advises differently, patients should take the entire recommended course of antibiotics to lower their chance of developing resistance and treatment failure.
What is the best way to avoid antibiotic resistance?
By following infection prevention procedures, avoiding self-medication, finishing treatment courses, and taking antibiotics only when recommended, one can lower the risk of antibiotic resistance.
Is the 90-60 rule approved for use in clinical settings?
The 90-60 rule, a well-known clinical observation, helps explain why patients’ results aren’t always accurately predicted by laboratory susceptibility results.
What is the 90-60 rule’s primary point?
The primary point is that while laboratory test results are significant, treatment decisions must also take into account the patient’s symptoms, clinical response, immune status, and general health condition.
Medical Disclaimer
Medical Disclaimer:
This article is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Antibiotic selection and treatment decisions should always be made by a qualified healthcare professional based on clinical evaluation, laboratory findings, and individual patient factors. Never start, stop, or change antibiotics without consulting your doctor. Misuse of antibiotics can contribute to antimicrobial resistance and may lead to serious health complications.
What to Avoid While Taking Doxycycline
https://healthuseful.com/what-to-avoid-while-taking-doxycycline/
Cluster 1: Antibiotics, Doxycycline & Medication Safety
Pillar Article
Doxycycline Cluster
- https://healthuseful.com/will-doxycycline-clear-tonsillitis/
- https://healthuseful.com/how-do-i-protect-my-gut-while-taking-doxycycline/
- https://healthuseful.com/can-i-drink-milk-with-doxycycline/
- https://healthuseful.com/what-happens-if-you-dont-drink-enough-water-with-doxycycline/
- https://healthuseful.com/what-is-the-most-common-side-effect-of-doxycycline/
- https://healthuseful.com/what-foods-should-i-avoid-while-taking-doxycycline/
Antibiotic Use & Safety
- https://healthuseful.com/cefuroxime-and-adenoid-infections-effective-or-not/
- https://healthuseful.com/are-bacterial-sinus-infections-contagious-while-on-antibiotics/
Medication Safety
- https://healthuseful.com/drugs-to-be-avoided-in-certain-circumstances/
- https://healthuseful.com/drugs-to-be-avoided-in-certain-circumstances-2/
Cluster 2: Sinus Infection & Sinusitis
Pillar Article
Cluster 3: Allergy & Drug Reactions
Pillar Article
Supporting Articles
- https://healthuseful.com/drugs-to-be-avoided-in-certain-circumstances/
- https://healthuseful.com/drugs-to-be-avoided-in-certain-circumstances-2/
- https://healthuseful.com/what-is-the-most-common-side-effect-of-doxycycline/
Cluster 4: Nasal Disorders
Pillar Article
Cluster 5: Ear Disorders & Hearing Health
Pillar Article
Cluster 6: Common Cold & Upper Respiratory Infections
Pillar Article
References
- World Health Organization (WHO). Antimicrobial Resistance.
https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance - World Health Organization (WHO). AWaRe Classification Database for Antibiotics.
https://aware.essentialmeds.org - Centers for Disease Control and Prevention (CDC). Antibiotic Use and Antimicrobial Resistance.
https://www.cdc.gov/antibiotic-use - Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing.
- European Committee on Antimicrobial Susceptibility Testing (EUCAST).
https://www.eucast.org - Kahlmeter G. The 90–60 Rule and Clinical Outcomes in Antimicrobial Therapy. Clinical Microbiology and Infection.
- World Health Organization (WHO). Bacterial Priority Pathogens List 2024.
https://www.who.int - Infectious Diseases Society of America (IDSA). Antimicrobial Stewardship Guidelines.
https://www.idsociety.org - National Institute for Health and Care Excellence (NICE). Antimicrobial Stewardship.
https://www.nice.org.uk - Centers for Disease Control and Prevention (CDC). Core Elements of Hospital Antibiotic Stewardship Programs.
https://www.cdc.gov/antibiotic-use/core-elements
